Author: Leung, T. Y. M.; Chan, A. Y. L.; Chan, E. W.; Chan, V. K. Y.; Chui, C. S. L.; Cowling, B. J.; Gao, L.; Ge, M. Q.; Hung, I. F. N.; Ip, M. S. M.; Ip, P.; Lau, K. K.; Lau, C. S.; Lau, L. K. W.; Leung, W. K.; Li, X.; Luo, H.; Man, K. K. C.; Ng, V. W. S.; Siu, C. W.; Wan, E. Y. F.; Wing, Y. K.; Wong, C. S. M.; Wong, K. H. T.; Wong, I. C. K.
Title: Short- and potential long-term adverse health outcomes of COVID-19: a rapid review Cord-id: n1mprcdc Document date: 2020_10_7
ID: n1mprcdc
Snippet: The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the cu
Document: The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the current evidence on the short-term adverse health outcomes and assesses the risk of potential long-term adverse outcomes of COVID-19. Major adverse outcomes were found to affect different body systems: immune system (including but not limited to Guillain-Barré syndrome and paediatric inflammatory multisystem syndrome), respiratory system (lung fibrosis and pulmonary thromboembolism), cardiovascular system (cardiomyopathy and coagulopathy), neurological system (sensory dysfunction and stroke), as well as cutaneous and gastrointestinal manifestations, impaired hepatic and renal function. Mental health in patients with COVID-19 was also found to be adversely affected. The burden of caring for COVID-19 survivors is likely to be huge. Therefore, it is important for policy makers to develop comprehensive strategies in providing resources and capacity in the healthcare system. Future epidemiological studies are needed to further investigate the long-term impact on COVID-19 survivors.
Search related documents:
Co phrase search for related documents- abdominal pain and acute kidney injury incidence: 1, 2
- abdominal pain and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain and acute treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- abdominal pain and additional number: 1
- abdominal pain vomiting nausea and acute kidney injury: 1, 2, 3, 4, 5, 6, 7
- abdominal pain vomiting nausea and acute phase: 1, 2, 3
- abdominal pain vomiting nausea and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain vomiting nausea and acute treatment: 1, 2
- abdominal pain vomiting nausea diarrhoea and acute respiratory syndrome: 1, 2, 3, 4, 5
- abdominal pain vomiting nausea diarrhoea and acute treatment: 1
- activate immune system and acute kidney injury: 1
- activate immune system and acute phase: 1
- activate immune system and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- actual incidence and acute respiratory syndrome: 1, 2, 3, 4, 5
- actual incidence and acute treatment: 1
- acute phase and additional reference: 1
- acute respiratory syndrome and additional number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory syndrome and additional reference: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date